See also this year's filing and all EDGAR filings for this company.
PDF Report 0001346830_2024_Tvardi_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001346830, Tvardi Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 116,158,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,322,000 |
| 3 | remainder_Assets | 6,364,000 |
| 4 | LiabilitiesCurrent | 25,592,000 |
| 5 | LiabilitiesNoncurrent | 6,088,000 |
| 6 | remainder_Liabilities | 37,079,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 35,097,649 |
| 9 | ResearchAndDevelopmentExpense | 128,494,831 |
| 10 | remainder_Expenses | 18,118,833 |
| 11 | remainder_Revenues | 20,681,549 |
| 12 | remainder_NetIncome | 3,438,669 |
| 13 | remainder_ComprehensiveNetIncome | 1,023,134 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 125,844,000 |
| 1 | Liabilities | 68,759,000 |
| 2 | Expenses | 181,711,313 |
| 3 | Revenues | 20,681,549 |
| 4 | StockholdersEquity | 57,085,000 |
| 5 | NetIncome | -157,591,095 |
| 6 | ComprehensiveNetIncome | -157,079,528 |
| 7 | BaseVar | 200,728,832 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.335 |
| 9 | EconomicCapitalRatio | 1.40 |
Edgar->Model Mapping
Feature Distribution
Change over Time
